Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin and Tolterodine Combination for Nocturia in Women with OAB
NCT01729819Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jan 2013
- Primary completion
- Nov 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of desmopressin in overactive bladder (OAB), nocturia, sponsored by Ferring Pharmaceuticals. Started Jan 2013; status: completed.
02
Drugs
desmopressin
03
Conditions
overactive bladder (OAB)nocturia
Beyond the preview
Go deeper on NCT01729819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01729819.